Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097487
Status:
COMPLETED
Last Update Posted:
2018-03-02
First Post:
2004-11-24
Brief Title:
A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Organization Data
Organization:
Genentech Inc
Class:
INDUSTRY
Study ID:
H2251n
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genentech Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None